Uncovering the Molecular Landscape of Secreted Phosphoprotein 1 and Its Expression Network in Kidney Renal Papillary Cell Carcinoma
Article Sidebar
Main Article Content
Abstract
Objective This study aims to investigate the expression pattern of Secreted Phosphoprotein 1 (SPP1), its prognostic relevance, and the associated co-expression gene network in kidney renal papillary cell carcinoma (KIRP).
Methods Publicly available transcriptomic and clinical datasets were analyzed using GEPIA, UALCAN, and the GTEx Portal. SPP1 expression levels in KIRP versus normal kidney tissues were evaluated, followed by Kaplan–Meier survival analysis stratified by ethnicity, gender, and body weight. Co-expression analysis was performed to identify genes significantly correlated with SPP1 and to explore their potential biological functions.
Results SPP1 expression was significantly upregulated in KIRP tissues compared with normal kidney tissues, consistent with GTEx data showing naturally high expression in kidney cortex and medulla. High SPP1 expression was associated with poorer overall survival, particularly among Caucasian patients, while no significant survival differences were observed by gender or body weight. Ten genes strongly co-expressed with SPP1, MLLT3, AKIRIN2, YIPF1, SESTD1, LAMC1, FAS, ABCC3, MTHFD1L, ANXA2P2, and ARHGAP29 were identified, many of which are implicated in cell adhe-sion, migration, extracellular matrix remodeling, and apoptosis resistance.
Conclusions SPP1 is markedly overexpressed in KIRP and correlates with unfavorable prognosis, highlighting its potential as a diagnostic and prognostic biomarker. The identified SPP1-associated co-expression gene network may offer novel insights and therapeutic targets for improving molecular-based interventions in KIRP.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Colavita JPM, Todaro JS, de Sousa M, May M, Gómez N, Yaneff A, et al. Multidrug resistance protein 4 (MRP4/ABCC4) is overexpressed in clear cell renal cell carcinoma (ccRCC) and is essential to regulate cell proliferation. Int J Biol Macromol. 2020;161:836-47.
Xie W, Zhang Y, Zhang Z, Li Q, Tao L, Zhang R. ISG15 promotes tumor progression via IL6/JAK2/STAT3 signaling pathway in ccRCC. Clin Exp Med. 2024; 24:140. PubMed PMID: 38951255
Wang B, Li M, Li R. Identification and verification of prognostic cancer subtype based on multi-omics analysis for kidney renal papillary cell carcinoma. Front Oncol. 2023;13:1169395. PubMed PMID: 37091151
Liu K, Hu H, Jiang H, Liu C, Zhang H, Gong S, et al. Upregulation of secreted phosphoprotein 1 affects malignant progression, prognosis, and resistance to cetuximab via the KRAS/MEK pathway in head and neck cancer. Mol Carcinog. 2020;59:1147-158.
Hsu LC, Li CJ, Lin LT, Pan LF, Wen ZH, Sheu JJ, et al. Multi-omics reveals the role of osteopontin/secreted phosphoprotein 1 in regulating ovarian aging. J Pers Med. 2024;14:78. PubMed PMID: 38248779
Zhang Z, Liu B, Lin Z, Mei L, Chen R, Li Z. SPP1 could be an immunological and prognostic biomarker: From pan-cancer comprehensive analysis to osteosarcoma validation. FASEB J. 2024;38(14):e23783. PubMed PMID: 39037571
Zhao G, Wang Y, Zhou J, Ma P, Wang S, Li N. Pan-cancer analysis of polo-like kinase family genes reveals polo-like kinase 1 as a novel oncogene in kidney renal papillary cell carcinoma. Heliyon. 2024 Apr 9;10(8):e29373. PubMed PMID: 38644836
Guo Z, Huang J, Wang Y, Liu XP, Li W, Yao J, et al. Analysis of expression and its clinical significance of the secreted phosphoprotein 1 in lung adenocarcinoma. Front Genet. 2020;11:547. PubMed PMID: 32595698
Zheng Y, Hao S, Xiang C, Han Y, Shang Y, Zhen Q, et al. The correlation between SPP1 and immune escape of EGFR mutant lung adenocarcinoma was explored by bioinformatics analysis. Front Oncol. 2021;11:592854. PubMed PMID: 34178613
Wang J, Hao F, Fei X, Chen Y. SPP1 functions as an enhancer of cell growth in hepatocellular carcinoma targeted by miR-181c. Am J Transl Res. 2019;11:6924-37.
Nedjadi T, Ahmed ME, Ansari HR, Aouabdi S, Al-Maghrabi J. Identification of SPP1 as a prognostic biomarker and immune cells modulator in urothelial bladder cancer: a bioinformatics analysis. Cancers (Basel). 2023 Dec 4;15(23):5704. PubMed PMID: 38067407
Li S, Yang R, Sun X, Miao S, Lu T, Wang Y, et al. Identification of SPP1 as a promising biomarker to predict clinical outcome of lung adenocarcinoma individuals. Gene. 2018;679:398-404. PubMed PMID: 30240883
Amukti DP, Wazni AR, Irham LM, Sulistyani N, Ma’ruf M, Adikusuma W, et al. Identifying pathogenic variants associated with Alzeimer by integrating genomic databases and bioinformatics approaches. InE3S Web of Conferences 2024 (Vol. 501, p. 01021). EDP Sciences.
Irham LM, Adikusuma W, La’ah AS, Chong R, Septama AW, Angelina M. Leveraging Genomic and Bioinformatic Analysis to Enhance Drug Repositioning for Dermatomyositis. Bioengineering (Basel).2023;10(8):890. PubMed PMID: 37627776
Li C, Tang Z, Zhang W, Ye Z, Liu F. GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res. 2021;49(W1):W242-W246. PubMed PMID: 34050758
Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98-W102. PubMed PMID: 28407145
Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, et al. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18-27.
Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK, et al. UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19:649-58.
Humolungo DT, Anjani R, Irham LM, Sulistyani N, Ma’ruf M, Amukti DP, et al. Identification of pathogenic gene variants in carpal tunnel syndrome using bioinformatics approaches. InE3S Web of Conferences 2024 (Vol. 501, p. 01022). EDP Sciences.
Gumelar G, Ulfa MM, Amukti DP, Irham LM, Yuliani S, Adikusuma W, et al. Harnessing genomic and bioinformatic data to broaden understanding of leukaemia across continents. Scripta Medica (Banja Luka). 2024;55:717–25.
Irham LM, Amukti DP, Adikusuma W, Singh D, Chong R, Basyuni M, et al. Applied of bioinformatics in drug discovery and drug development: bioinformatic analysis 1996-2024. In: BIO Web of Conferences. EDP Sciences; 2025.
Irham LM, Amukti DP, Adikusuma W, Singh D, Chong R, Basyuni M, et al. Applied of bioinformatics in drug discovery and drug development: bioinformatic analysis 1996-2024. In: BIO Web of Conferences. EDP Sciences; 2025.
Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019 Jul 2;47(W1):W556-W560. PubMed PMID: 31114875
Irham LM, Amukti DP, Adikusuma W, Singh D, Chong R, Pranata S, et al. Trends in drug repurposing for chronic hepatitis-B infection:bibliometric-basedapproach1990-2024. In: BIO Web of Conferences. EDP Sciences; 2025.
Liu Y, Cheng X, Xi P, Zhang Z, Sun T, Gong B. Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma. BMC Urol. 2023;23(1):54. PubMed PMID: 37004005
Sun G, Shang Z, Liu W. SPP1 regulates radiotherapy sensitivity of gastric adenocarcinoma via the Wnt/Beta-Catenin pathway. J Oncol. 2021;2021:1642852. PubMed PMID: 34367279
Chen K, Li Y, Ni J, Yang X, Zhou Y, Pang Y, et al. Identification of a novel subtype of SPP1 + macrophages expressing SIRP: implications for tumor immune evasion and treatment response prediction. Exp Hematol Oncol. 2024;13(1):119. PubMed PMID: 39696410
Zhao K, Ma Z, Zhang W. Comprehensive analysis to identify SPP1 as a prognostic biomarker in cervical cancer. Front Genet. 2022;12:732822. PubMed PMID
Xu X, Lin J, Wang J, Wang Y, Zhu Y, Wang J, et al. SPP1 expression indicates outcome of immunotherapy plus tyrosine kinase inhibition in advanced renal cell carcinoma. Hum Vaccin Immunother. 2024 Dec 31;20(1):2350101. PubMed PMID: 38738709
Zhang Y, Du W, Chen Z, Xiang C. Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma. Exp Cell Res. 2017;359:449-57. PubMed PMID: 28830685.
